Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
01/2007
01/11/2007US20070009996 Ginkgo biloba levopimaradiene synthase
01/11/2007US20070009995 Prevention of incorporation of non-standard amino acids into protein
01/11/2007US20070009994 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen
01/11/2007US20070009993 metRS2
01/11/2007US20070009992 Purified mutant DNA comprising a TLR4 human genomic segment; identifying polymorphisms; expression cassettes; nucleic acid molecule of operably linked to a promoter, so that host cell expresses variant TLR4; diagnosing susceptibility to asthma, respiratory system disorders, arthritis, cystic fibrosis
01/11/2007US20070009991 Gene expression in transgenic avians
01/11/2007US20070009990 Site-specific incorporation of redox active amino acids into proteins
01/11/2007US20070009989 Synthetic heparanase molecules and uses thereof
01/11/2007US20070009988 Leucine aminopeptidase polypeptide, carboxypeptidases polypeptide; dermatophyte; degradation, hydrolysis or maturation of polypeptide substrate; Exonuclease X of Escherichia coli ( EXOX protein); fungicides; dipeptidyl peptidase IV
01/11/2007US20070009987 recombinant fusion protein comprising binding domain antibody that binds to cell-surface antigen, functional group domain for eliciting desired effect on target molecule, extension peptide between binding domain and functional group domain containing uncoupled cysteine residue capable of forming s-s bond
01/11/2007US20070009985 Novel nitrile hydratase
01/11/2007US20070009981 Nematode phosphoethanolamine N-methyltransferase-like sequences
01/11/2007US20070009979 Cyclic GMP dependent protein kinase as a chemotherapeutic target for antiprotozoal agents
01/11/2007US20070009964 competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells
01/11/2007US20070009959 Methods for producing antibodies
01/11/2007US20070009957 Vectors used to create hybrid constant regions
01/11/2007US20070009955 Secreted polypeptide species associated with cardiovascular disorders
01/11/2007US20070009954 Parallel polymorphism scoring by amplification and error correction
01/11/2007US20070009953 Using capsid specific primer sequences to screen for and detect low concentrations of flaviviruses
01/11/2007US20070009950 Methods and compositions for vitamin K epoxide reductase
01/11/2007US20070009945 Endothelins; renin; kits
01/11/2007US20070009944 Assay for nucleic acid ligase and nucleic acid nuclease
01/11/2007US20070009941 Complementary DNAs
01/11/2007US20070009939 Preparation of nucleic acid samples
01/11/2007US20070009936 mTOR kinase-associated proteins
01/11/2007US20070009933 PGC-1beta, a novel PGC-1 homologue and uses therefor
01/11/2007US20070009927 Methods and compositions for prenatal diagnosis of mental retardation
01/11/2007US20070009924 Thermococcus zilligii DNA polymerases and variants thereof
01/11/2007US20070009922 Hot start polymerase reaction using a thermolabile blocker
01/11/2007US20070009916 Guanosine triphosphate-binding protein coupled receptors
01/11/2007US20070009910 Primers, probes and reference plasmid for detection of meat adulteration
01/11/2007US20070009908 Human stanniocalcin-alpha
01/11/2007US20070009906 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
01/11/2007US20070009905 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
01/11/2007US20070009904 Reagents for diagnosis of bacterial infection, components of effective antibacterial vaccines, and/or as targets for antibacterial drugs, including anti-S. pneumoniae drugs
01/11/2007US20070009903 Reagents for diagnosis of bacterial infection, components of antibacterial vaccines, and/or as targets for antibacterial drugs
01/11/2007US20070009902 Nucleotide sequences coding bacterial surface protein for use in development of vaccines and prevention of infection
01/11/2007US20070009901 molecular targets for diagnostics, prophylaxis and treatment of bacterial infection;
01/11/2007US20070009900 Vectors; cells; drug targets
01/11/2007US20070009899 Nucleic acid arrays for detecting gene expression in animal models of inflammatory diseases
01/11/2007US20070009897 Method of detecting genetic polymorphism
01/11/2007US20070009893 Method for isolating and purifying a nucleic acid
01/11/2007US20070009890 Screen for novel protein inhibitors based upon engineered cell line containing an inducible overactivity gene and compensatory gene
01/11/2007US20070009889 Nucleoside derivative, modifed oligonucleotide, method for their syntesis and applicantions thereof
01/11/2007US20070009888 Compositions, splice variants and methods relating to breast specific genes and proteins
01/11/2007US20070009887 Genotyping of deafness by oligonucleotide microarray analysis
01/11/2007US20070009886 Carbohydrate-associated proteins
01/11/2007US20070009552 Simultaneous protection against each of the four dengue viruses, thereby precluding the possibility of developing the more serious illnesses dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), which occur in humans during secondary infection with a heterotypic wild-type dengue virus
01/11/2007US20070009551 Aids ancestral viruses and vaccines
01/11/2007US20070009546 Isolated nucleic acid; screening for antibacterial compounds
01/11/2007US20070009528 Antibodies to masp-2
01/11/2007US20070009526 Anti-IL-23 antibodies, compositions, methods and uses
01/11/2007US20070009525 Human Endokine Alpha and Methods of Use
01/11/2007US20070009524 Methods of treating inflammation associated with viral infection with anti-tnf antibodies
01/11/2007US20070009523 Polypeptide variants with altered effector function
01/11/2007US20070009521 Human tumor necrosis factor TR21 and methods based thereon
01/11/2007US20070009520 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders
01/11/2007US20070009516 Immune response-associated proteins
01/11/2007US20070009515 Inflammatory skin disease-related slurp-2 gene and utilization thereof
01/11/2007US20070009514 Prostaglandin receptor ep1
01/11/2007US20070009498 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
01/11/2007US20070009488 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules
01/11/2007US20070009482 Stimulant of immunology response; viricides
01/11/2007US20070009477 Methods for rational PEGylation of proteins
01/11/2007US20070009476 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same
01/11/2007US20070009442 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules
01/11/2007US20070009435 Compositions and methods for enhanced delivery to target sites
01/11/2007DE19713543B4 Bakterielle Plasmide Bacterial plasmids
01/11/2007DE102005031755A1 New peptides that bind to Salmonella, useful for immobilization, detection, concentration and labeling, optionally derivatized with a pharmaceutical
01/11/2007CA2613818A1 Anti-il-23 antibodies, compositions, methods and uses
01/11/2007CA2613442A1 Materials and methods for the generation of fully 2'-modified nucleic acid transcripts
01/11/2007CA2613386A1 Cyanine dyes and methods of use in biological applications
01/10/2007EP1742058A2 Substrate for analyte determination and methods for manufacturing such substrates
01/10/2007EP1741781A2 RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
01/10/2007EP1741779A2 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine mediated toxicity
01/10/2007EP1741718A2 Expression of lipoproteins
01/10/2007EP1740713A2 Synthetic genes
01/10/2007EP1740712A2 Lactoferrin cleavage of neisserial proteins
01/10/2007EP1740615A2 Humanized anti-tgf-beta antibodies
01/10/2007EP1740600A1 Intracellular delivery of osteoinductive proteins and peptides
01/10/2007EP1740220A2 Non-natural ribonuclease conjugates as cytotoxic agents
01/10/2007EP1740210A2 Irta-5 antibodies and their uses
01/10/2007EP1740167A2 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor
01/10/2007EP1578764A4 Thymidylate synthase polymorphisms for use in screening for cancer susceptibility
01/10/2007EP1556405A4 Mutations in nod2 are associated with fibrostenosing disease in patients with crohn's disease
01/10/2007EP0782580B1 Parallel selex
01/10/2007CN1894276A HCV NS3-NS4A protease resistance mutants
01/10/2007CN1893958A Nucleic acid and corresponding protein entitle 98P4B6 useful in treatment and detection of cancer
01/10/2007CN1891833A Enzyme reaction method for nucleic acid and composition for separating nucleic acid
01/10/2007CN1891825A Gene and protein relating to hepatocellular carcinoma
01/10/2007CN1891238A Method for preparing nutrient liquid containing nucleic acid and nucleic acid raw material using biological cell
01/10/2007CN1294276C Length equivalent double chain specific probe for nucleic acid detection
01/09/2007USRE39464 Oligonucleolotides having site specific chiral phosphorothioate internucleoside linkages
01/09/2007US7161060 Transgenic mice comprising a genomic human tau transgene
01/09/2007US7160998 Monitoring amplification with fret probes
01/09/2007US7160997 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms
01/09/2007US7160996 Fluorescence energy transfer probes with stabilized conformations
01/09/2007US7160994 Osteoclast-specific genes and proteins and uses thereof
01/09/2007US7160993 Nucleic acids encoding PRO4400 polypeptides
01/09/2007US7160985 For therapy of diabetes